Valuation, page-59

One could be forgiven for saying its not rocket science.. but it sort of is I guess..
The potential is spelt out pretty clear (that bits not rocket science), the execution is the hard bit and is especially so with medicals.. but the upside is just so cool.
By the time they are putting this into final trials the price will be multitudes of current.. that’s why plenty were willing to fork out at ipo..

Price will go up and down.. that’s pretty normal,, but I am guessing it will be up on high volume and down on low volume..

It’s a while since I have been this keen.. on a stock..

GLTAH